Patrick van Dooren

Provides business intelligence applications and analytics services

Part of IQVIA Holdings, Inc., IQVIA RDS & Integrated Services Belgium NV is a Belgian life sciences company specializing in advanced, AI-driven solutions tailored for the healthcare and pharmaceutical industries. The company is based in Zaventem, Belgium. The company provides services in clinical development, real-world evidence generation, commercialization, safety, and regulatory compliance, covering therapeutic areas such as ophthalmology, biosimilars, cell and gene therapies, allergy and respiratory diseases, oncology, and rare diseases. IQVIA integrates healthcare-grade AI technologies and advanced analytics to optimize clinical trial design, execution, and financial management through platforms like the Clinical Trial Financial Suite and the IQVIA Site Suite, which streamline budgeting, contracting, payments, and site-sponsor interactions. The company’s multidisciplinary teams support complex and adaptive trial designs, patient-centric approaches, and decentralized trial solutions. IQVIA collaborates with industry leaders and participates in consortia to accelerate drug development and improve patient outcomes, using its Connected Intelligence™ platform to integrate diverse data sources and predictive modeling for informed decision-making. The CEOs are Clotilde Ghysselinckx, Emmanuel Vanderhaegen, Laurence Nigot. The company was founded in 1996.